Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells

Emma Sandilands1, Bryan Serrels, Simon Wilkinson

  • 1Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XR, UK. e.sandilands@ed.ac.uk

EMBO Reports
|June 27, 2012
PubMed

Insights

Autophagy degrades Ret tyrosine kinase in cancer cells with defective FAK signaling, a process mediated by Src. This mechanism promotes cancer cell survival, offering a new therapeutic target.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Autophagic targeting of Src kinase supports cancer cell survival when focal adhesion kinase (FAK) signaling is impaired.
  • Adhesion-dependent signaling pathways are crucial for cancer cell survival and are often dysregulated in cancer.

Purpose of the Study:

  • To investigate the role of autophagy in regulating other adhesion-linked tyrosine kinases beyond Src.
  • To determine if Ret tyrosine kinase is also a substrate for autophagic degradation in cancer cells with altered FAK signaling.

Main Methods:

  • Utilized cancer cell models with defective FAK signaling.
  • Employed autophagy inhibition and Src kinase activity inhibition as experimental manipulations.
  • Assessed Ret localization to focal adhesions and its degradation via autophagy.
  • Investigated the role of Src in mediating the autophagic targeting of Ret.

Main Results:

  • Ret tyrosine kinase is degraded by autophagy in cancer cells with reduced FAK signaling.
  • Autophagy inhibition restores Ret localization to focal adhesions.
  • Src kinase activity is essential for targeting Ret to autophagosomes and promoting its degradation.
  • Src acts as a mediator for the selective autophagic degradation of adhesion-linked kinases, including Ret.

Conclusions:

  • Src mediates the autophagic degradation of Ret, a FAK-binding tyrosine kinase, under conditions of adhesion stress.
  • This autophagic pathway involving Src and Ret contributes to cancer cell survival.
  • Targeting this selective autophagy mechanism represents a potential therapeutic strategy for cancer treatment.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...